Bio regulatory requirements of pressurized metered dose inhaler (pmdi) and optimizing in- vitro characterization of inhaler
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: AGGARWAL, Deepika (Hyderabad, India)
Background: This covers the current status of regulatory complexity on establishing the bioequivalence of pMDI the limitations of in vitro and in vivo bioequivalence testing, and the practical issues associated with various approaches Objective: Since the in-vitro results are correlating with the in vivo study, before going ahead with the PK and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.